文献速递烧伤创面修复

改性淀粉粉末与肾上腺素纱布在烧伤清创止血中的随机对照研究

Modified starch powder versus epinephrine gauze for hemostasis during burn wound debridement: A randomized intra-patient trial.
PubMed 文献 · Burns · 2026-06-13

这项前瞻性随机自身对照试验纳入30例烧伤清创患者,比较改性淀粉粉末(AriClot)与肾上腺素饱和纱布的止血效果。结果显示淀粉粉末组止血时间显著更短、出血流速更低、术者满意度更高、创面感染更少,而皮片丢失和缺血无显著差异。

要点

  • 淀粉粉末组止血时间中位1.5分钟,显著短于肾上腺素纱布组的5分钟。
  • 淀粉粉末组出血流速中位3 ml/min/TBSA%,显著低于对照组7 ml/min/TBSA%。
  • 淀粉粉末组76.67%应用评为「完美」,对照组仅10%,创面感染显著更低。

核心结论

  • 羧甲基淀粉基止血剂在烧伤清创中止血效果优于肾上腺素饱和纱布,止血更快、术者满意度更高,且不增加不良创面结局风险。

研究设计与样本

  • 前瞻性、随机、自身对照试验,纳入30例接受烧伤清创的患者,每个患者两个可比创面随机接受淀粉粉末或肾上腺素饱和纱布。

主要发现

  • 淀粉粉末组止血时间中位1.5分钟 vs 对照组5分钟,p < 0.001。
  • 淀粉粉末组出血流速中位3 ml/min/TBSA% vs 对照组7 ml/min/TBSA%,p < 0.001。
  • 淀粉粉末组76.67%应用评为「完美」,对照组10%,p < 0.001。
  • 淀粉粉末组创面感染显著更低,p = 0.027。
  • 两组皮片排斥(p = 0.275)和缺血(p = 0.220)无统计学显著差异。

临床怎么用

  • 烧伤清创术中可考虑使用羧甲基淀粉基止血剂替代肾上腺素饱和纱布,以加快止血并提高术者满意度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe intraoperative hemorrhage during burn wound debridement is a major challenge. Topical hemostatics help rapidly control bleeding, but agents must be effective, safe, and easy to use. This study compared a modified starch powder with standard epinephrine-saturated gauze for hemorrhage control during burn wound debridement. METHODS: A prospective, randomized, intra-patient-controlled trial was conducted with 30 patients undergoing burn debridement. For each patient, two comparable wound sites were randomized to receive starch powder (AriClot) or epinephrine-saturated gauze. The primary outcomes were time to hemostasis and bleeding flow rate. Secondary outcomes included surgeon satisfaction, early graft loss, ischemia, and wound infection. Statistical analysis was performed using appropriate paired tests. RESULTS: The starch powder-treated sites had a significantly shorter time to hemostasis (median 1.5 min vs. 5 min; p < 0.001) and a significantly lower bleeding flow rate than the control sites (median 3 ml/min/TBSA% vs. 7 ml/min/TBSA%; p < 0.001). Surgeon satisfaction was notably higher with starch powder, with 76.67% of applications rated as "Perfect" compared with 10% for the control treatment (p < 0.001). Wound site infection was significantly lower with starch powder (p = 0.027). There were no statistically significant differences in graft rejection (p = 0.275) or ischemia (p = 0.220) between the two intervention sites. CONCLUSION: Carboxymethyl starch-based hemostatic agent improved hemostasis compared with epinephrine-saturated gauze during burn wound debridement. Its use was associated with faster hemostasis and higher surgeon satisfaction, without increasing the risk of adverse wound outcomes. CLINICAL TRIAL REGISTRATION NUMBER: IRCT20180609040016N6 (https://irct.behdasht.gov.ir/trial/78594).

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Keshavarzi A, Shahin K, Rahimizadeh N, et al. Modified starch powder versus epinephrine gauze for hemostasis during burn wound debridement: A randomized intra-patient trial. Burns. 2026. PMID: 42407280. doi:10.1016/j.burns.2026.108111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。